2025.Jul.28
Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO
Date of the board of directors resolution:2025/07/28 Name and title of the managerial officer with permission to engage in competitive conduct:Patricia Chou / CEO Items of competitive conduct in which the officer is permitted to engage:Scope of business is similar to that of OBIGEN Pharma Period of permission to engage in the competitive conduct:Duration of […]
This article is password protected.
To view the content, please enter your password in the field below